Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 59.02
-2.89 (-4.67%)
May 12, 2026, 3:04 PM CST
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 7.67 billion as of May 12, 2026. Its market cap has decreased by -4.01% in one year.
Market Cap
7.67B
Enterprise Value
6.64B
Revenue
1.20B
Ranking
n/a
PE Ratio
33.85
Stock Price
59.02
Market Cap Chart
Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 7.67B, an increase of 26.15%. That is a compound annual growth rate of 4.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 7.67B | -18.32% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Thera Solutions | 8.30B |
| Nanjing Vazyme Biotech | 8.10B |
| Shanghai Medicilon | 8.06B |
| Acrobiosystems | 7.69B |
| Suzhou Fengbei Biotech Stock | 7.28B |
| Jiangsu Aidea Pharmaceutical Group | 7.23B |
| Shanghai OPM Biosciences | 7.23B |
| Xiangxue Pharmaceutical | 6.99B |